研究成果: |
探究了HGPS儿童早老症细胞衰老的新机制,针对新靶点提出治疗HGPS的潜在新策略,并解析了细胞衰老在肿瘤进程中作用的新机制。先后在Nature Aging、EMBO Journal等知名期刊发表学术论文13余篇。参与国家和省部级科研项目6项,申请国家专利2项。发表在Nature Aging期刊上的文章入选Nature期刊“Research Highlights”专栏,同时美国马里兰大学Huijing Xu 等在同期Nature Aging 杂志“News & Views”专栏发表评论文章。 代表性期刊论文(近五年): 1. Zhang N#, Hu Q#, Sui T, Fu L, Zhang X, Wang Y, Zhu X, Huang B, Lu J*, Li Zhan*, Zhang Y*. Unique progerin-C terminal peptide ameliorates Hutchinson-Gilford Progeria Syndrome phenotype by rescuing BUBR1. Nature Aging,2023, 3(2):185-201. 2. Hu Q#, Zhang N#, Li G, Wang Z, Huang B, Lu J*, Zhang Y*. Anti-novel-miR-59 alleviates premature senescence of Hutchinson-Gilford progeria syndrome by regulating HMGA1-mediated transcription. Embo Journal. 2022, e110937. 3. Zhang N, Shang M, Li H, Wu L, Dong M, Huang B, Lu J, Zhang Y*. Dual inhibition of H3K9me2 and H3K27me3 promotes tumor cell senescence without triggering the secretion of SASP.International Journal of Molecular Sciences, 2022, 23, 3911。 4. Zhang N#, Ji J#, Zhou D, Liu X, Zhang X, Liu Y, Xiang W, Wang M, Zhang L, Wang G, Huang B, Lu J, Zhang Y*. Doxorubicin induced senescence of breast cancer MCF-7 cells promotes EMT through activating Notch signaling. InternationalJournal of Molecular Sciences, 2021, 22, 849. 5. Lin C, Li H, Liu J, Hu Q, Zhang S, Zhang N, Liu L, Dai Y, Cao D, Li X, Huang B, Lu J*, Zhang Y*. Arginine hypomethylation-mediated proteasomal degradation of histone H4 — an early biomarker of cellular senescence. Cell Death and Differentiation 2020, 27, 2697-2709. 6. Liu J, Feng J, Li L, Lin L, Ji J, Lin C, Liu L, Zhang N, Duan D, Li Z, Huang B, Zhang Y*, Lu J*.Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. EMBO Reports, 2020, 21(2): e48597. 7. Liu L, Zhang X, Ding H, Liu X, Cao D, Liu Y, Liu J, Lin C,Zhang N, Wang G, Hou J, Huang B, Zhang Y*, Lu J*. Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS. Oncogene,2021, 40(20): 3548-3563. 申请国家发明专利 1. 一种多肽UPCP 及其在制备治疗衰老产品中的应用(专利号202210268780.2,1/4) 2. 一种新型肽UPCP 在器官纤维化治疗中的作用(专利号202211088525.6, 3/6)
|